UNSPSC 85742526: Supplement left fallopian tube with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left fallopian tube with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0UU647Z

UNSPSC 85742526 Supplement left fallopian tube with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent activity under state and local procurement. The UNSPSC designation—a specific surgical procedure code—does not align with the recent opportunities posted under this code, which center instead on occupational health surveillance, disability medical evaluation services, surgical benefit administration, pharmacy benefit management, temporary health professional staffing, and emergency medical services for detained youth. State and local governments do not procure individual surgical procedures through the competitive solicitation process that generates the opportunities visible in procurement databases; this code appears to have been misapplied to general medical services contracting rather than to procedure-specific supply or vendor selection. No state or local purchasing activity directly matching the code's nominal scope has been documented in recent months.

The recent opportunities tagged to this code originate from diverse issuing bodies—city retirement boards (Phoenix), municipal employee benefits programs (Long Beach, Collier County), state transportation agencies (Washington State Department of Transportation), county health systems (Santa Clara, Harris County), and county probation departments—and span Arizona, California, Florida, and Washington. However, none of these opportunities involve the acquisition of the fallopian-tube supplementation procedure, tissue substitutes, or the technical services surrounding that specific surgical intervention. Unless state and local procurement practice has shifted to bundle highly specific procedural codes with broader healthcare administration and staffing services, this code should not be relied upon as an indicator of current market opportunity.